Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Dynamically expressed microRNA-15b modulates the activities of CD8+ T lymphocytes in mice with Lewis lung carcinoma.

Zhong G, Cheng X, Long H, He L, Qi W, Xiang T, Zhao Z, Zhu B.

J Transl Med. 2013 Mar 21;11:71. doi: 10.1186/1479-5876-11-71.

2.

miRNA profiling of naïve, effector and memory CD8 T cells.

Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, Manjunath N.

PLoS One. 2007 Oct 10;2(10):e1020.

3.
4.

miR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure.

An F, Gong B, Wang H, Yu D, Zhao G, Lin L, Tang W, Yu H, Bao S, Xie Q.

Apoptosis. 2012 Jul;17(7):702-16. doi: 10.1007/s10495-012-0704-7.

PMID:
22374434
5.

miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis.

Guo CJ, Pan Q, Li DG, Sun H, Liu BW.

J Hepatol. 2009 Apr;50(4):766-78. doi: 10.1016/j.jhep.2008.11.025. Epub 2009 Feb 2.

PMID:
19232449
6.
7.

MicroRNA regulation in human CD8+ T cell subsets--cytokine exposure alone drives miR-146a expression.

Sheppard HM, Verdon D, Brooks AE, Feisst V, Ho YY, Lorenz N, Fan V, Birch NP, Didsbury A, Dunbar PR.

J Transl Med. 2014 Oct 21;12:292. doi: 10.1186/s12967-014-0292-0.

8.
9.

Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity.

Kemp RA, Ronchese F.

J Immunol. 2001 Dec 1;167(11):6497-502.

10.

Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells.

Kato M, Nakamura Y, Suda T, Ozawa Y, Inui N, Seo N, Nagata T, Koide Y, Kalinski P, Nakamura H, Chida K.

Cancer Immunol Immunother. 2011 Jul;60(7):1029-38. doi: 10.1007/s00262-011-1015-5. Epub 2011 Apr 26.

PMID:
21519830
11.

Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression.

Redmond WL, Triplett T, Floyd K, Weinberg AD.

PLoS One. 2012;7(4):e34467. doi: 10.1371/journal.pone.0034467. Epub 2012 Apr 4.

12.
13.

IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response.

Apte SH, Groves P, Olver S, Baz A, Doolan DL, Kelso A, Kienzle N.

J Immunol. 2010 Jul 15;185(2):998-1004. doi: 10.4049/jimmunol.0903372. Epub 2010 Jun 18.

14.

The TGF-β-inducible miR-23a cluster attenuates IFN-γ levels and antigen-specific cytotoxicity in human CD8⁺ T cells.

Chandran PA, Keller A, Weinmann L, Seida AA, Braun M, Andreev K, Fischer B, Horn E, Schwinn S, Junker M, Houben R, Dombrowski Y, Dietl J, Finotto S, Wölfl M, Meister G, Wischhusen J.

J Leukoc Biol. 2014 Oct;96(4):633-45. doi: 10.1189/jlb.3A0114-025R. Epub 2014 Jul 16.

15.
16.

Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo.

Prévost-Blondel A, Roth E, Rosenthal FM, Pircher H.

J Immunol. 2000 Apr 1;164(7):3645-51.

17.

Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAM.

Cai Y, Xiong S, Zheng Y, Luo F, Jiang P, Chu Y.

Cell Mol Immunol. 2011 Jul;8(4):359-67. doi: 10.1038/cmi.2011.12. Epub 2011 May 16.

18.

Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.

Chen F, Chen C, Yang S, Gong W, Wang Y, Cianflone K, Tang J, Wang DW.

PLoS One. 2012;7(6):e39197. doi: 10.1371/journal.pone.0039197. Epub 2012 Jun 25.

19.

[Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].

Han LF, Qiu WM, Hu C, Wang L, Yao HX, Xiong SY, Meng M, Fang Y, Ma D.

Zhonghua Fu Chan Ke Za Zhi. 2010 Aug;45(8):603-8. Chinese.

PMID:
21029617
20.

[Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].

Ren T, Cai YY, Liang YJ, Jin ML, Guo ZL, Tao MF, He X.

Zhonghua Yi Xue Za Zhi. 2008 Apr 29;88(17):1168-72. Chinese.

PMID:
18844109

Supplemental Content

Support Center